MS patients on anti-CD20 therapy have robust T cell responses to SARS-CoV-2 vaccination

By | August 28, 2021
Scientists have observed that MS patients exhibit a robust T cell response despite a reduced humoral response to COVID-19 vaccines. Read more here.